Indevus Pharmaceuticals Inc.

(NASDAQ:IDEV)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Assets
Current Assets
Cash & Equivalents 131,306 52,624 60,765 82,300
Restricted Cash 5,150 — — —
Marketable Securities — — — —
Accounts Receivable 14,512 10,834 11,737 10,426
Loans Receivable — — — —
Other Receivable — — — —
Receivables 14,512 10,834 11,737 10,426
Raw Materials 1,424 — — —
Work in Progress 3,215 — — —
Purchased Components — — — —
Finished Goods — — — —
Other Inventories 1,540 10,064 11,344 9,193
Inventories Adjustments and Allowances — — — —
Inventories 6,179 10,064 11,344 9,193
Prepaid Expenses 4,998 5,770 3,548 5,453
Current Deferred Income Taxes — — — —
Other Current Assets — — — —
Total Current Assets 162,145 79,292 87,394 107,372
Land and Improvements — — — —
Building and Improvements 6,830 6,814 6,800 6,801
Machinery Furniture and Equipment 6,366 6,417 5,180 4,805
Construction in Progress 124 182 1,904 538
Other Fixed Assets — — — —
Total Fixed Assets 13,320 13,413 13,884 12,144
Gross Fixed Assets 13,320 13,413 13,884 12,144
Accumulated Depreciation and Depletion 4,096 3,586 2,932 2,408
Net Fixed Assets 9,224 9,827 10,952 9,736
Intangibles 30,855 31,492 28,197 28,693
Cost in Excess 48,244 48,244 48,244 48,244
Non Current Deferred Income Taxes — — — —
Other Non Current Assets 12,534 4,903 5,293 4,601
Total Non Current Assets 100,857 94,466 92,686 91,274
Total Assets 263,002 173,758 180,080 198,646
Liabilities
Current Liabilities
Accounts Payable 7,338 6,855 7,727 2,706
Notes Payable 70,187 75 75 75
Short Term Debt — — — —
Accrued Expenses 16,116 20,455 18,162 21,397
Accrued Liabilities 2,582 2,075 950 2,075
Deferred Revenues 46,766 43,424 42,202 41,137
Current Deferred Income Tax Liabilities — — — —
Other Current Liabilities — — — —
Total Current Liabilities 142,989 72,884 69,116 67,390
Non Current Liabilities
Long Term Debt 105,000 69,638 69,089 68,540
Capital Lease Obligations — — — —
Deferred Income Tax Liabilities — — — —
Other Non Current Liabilities 145,199 149,299 143,176 148,289
Minority Interest Liabilities — — — —
Preferred Securities of Subsidiary Trust Liabilities — — — —
Preferred Equity Outside Stock Equity — — — —
Total Non Current Liabilities 393,188 291,821 281,381 284,219
Total Liabilities 250,199 218,937 212,265 216,829
Shareholders' Equity
Preferred Stock Equity — — 3,500 3,500
Common Stock Equity -130,186 -118,063 -104,801 -89,073
Common Par 78 78 76 77
Additional Paid in Capital 511,788 509,934 504,233 502,054
Cumulative Translation Adjustment — — — —
Retained Earnings -642,052 -628,075 -609,110 -591,204
Treasury Stock — — — —
Other Equity Adjustments — — — —
Total Capitalization -25,186 -48,425 -32,212 -17,033
Cash Flow -58,475 -53,752 -108,114 -104,065
Working Capital 19,156 6,408 18,278 39,982
Free Cash Flow -33,685 -21,059 -12,758 9,297
Invested Capital -25,186 -48,425 -32,212 -17,033
Total Equity -130,186 -118,063 -101,301 -85,573
Total Liabilities and Stock Equity 263,002 173,758 180,080 198,646